Top Markets
#1 QuantixAI QuantixAI +45.25%
#2 MowCat MowCat +27.33%
#3 Prom Prom +22.38%
#4 Tutorial Tutorial +19.96%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +18.39%
#6 UnifAI Network UnifAI Network +17.56%
#7 Versatize Coin Versatize Coin +16.67%
#8 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +15.07%
#9 Pons Pons +12.75%
#10 StonkBroker StonkBroker +10.95%
Coin of the day
QuantixAI QuantixAI
Settings
Language
ENGLISH
Currency
USD
Theme
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Rank in Stocks #20647
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Share Price
$0.517
Last synced: 2026-08-21
Market Cap
$125.14M
Change (1 day)
-0.58%
Change (1 year)
47.71%
Country
US
Trade Vaxart, Inc. (VXRT)

Category

Healthcare
P/S ratio for Vaxart, Inc. (VXRT)
P/S ratio as of 2026 TTM: 0
According to Vaxart, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Vaxart, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH